 |
|
JAMA-EXPRESS
Vitamins E and C in the Prevention of Prostate and Total Cancer in MenThe Physicians' Health Study II Randomized Controlled Trial
J. Michael Gaziano, MD, MPH;
Robert J. Glynn, ScD;
William G. Christen, ScD;
Tobias Kurth, MD, ScD;
Charlene Belanger, MA;
Jean MacFadyen, BA;
Vadim Bubes, PhD;
JoAnn E. Manson, MD, DrPH;
Howard D. Sesso, ScD, MPH;
Julie E. Buring, ScD
JAMA. 2009;301(1):(doi:10.1001/jama.2008.862).
Context Many individuals take vitamins in the hopes of preventing chronic diseases such as cancer, and vitamins E and C are among the most common individual supplements. A large-scale randomized trial suggested that vitamin E may reduce risk of prostate cancer; however, few trials have been powered to address this relationship. No previous trial in men at usual risk has examined vitamin C alone in the prevention of cancer.
Objective To evaluate whether long-term vitamin E or C supplementation decreases risk of prostate and total cancer events among men.
Design, Setting, and Participants The Physicians' Health Study II is a randomized, double-blind, placebo-controlled factorial trial of vitamins E and C that began in 1997 and continued until its scheduled completion on August 31, 2007. A total of 14 641 male physicians in the United States initially aged 50 years or older, including 1307 men with a history of prior cancer at randomization, were enrolled.
Intervention Individual supplements of 400 IU of vitamin E every other day and 500 mg of vitamin C daily.
Main Outcome Measures Prostate and total cancer.
Results During a mean follow-up of 8.0 years, there were 1008 confirmed incident cases of prostate cancer and 1943 total cancers. Compared with placebo, vitamin E had no effect on the incidence of prostate cancer (active and placebo vitamin E groups, 9.1 and 9.5 events per 1000 person-years; hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.85-1.09; P = .58) or total cancer (active and placebo vitamin E groups, 17.8 and 17.3 cases per 1000 person-years; HR, 1.04; 95% CI, 0.95-1.13; P = .41). There was also no significant effect of vitamin C on total cancer (active and placebo vitamin C groups, 17.6 and 17.5 events per 1000 person-years; HR, 1.01; 95% CI, 0.92-1.10; P = .86) or prostate cancer (active and placebo vitamin C groups, 9.4 and 9.2 cases per 1000 person-years; HR, 1.02; 95% CI, 0.90-1.15; P = .80). Neither vitamin E nor vitamin C had a significant effect on colorectal, lung, or other site-specific cancers. Adjustment for adherence and exclusion of the first 4 or 6 years of follow-up did not alter the results. Stratification by various cancer risk factors demonstrated no significant modification of the effect of vitamin E on prostate cancer risk or either agent on total cancer risk.
Conclusions In this large, long-term trial of male physicians, neither vitamin E nor C supplementation reduced the risk of prostate or total cancer. These data provide no support for the use of these supplements for the prevention of cancer in middle-aged and older men.
Trial Registration clinicaltrials.gov Identifier: NCT00270647
Author Affiliations: Divisions of Preventive Medicine (Drs Gaziano, Glynn, Christen, Kurth, Bubes, Manson, Sesso, and Buring and Mss Belanger and MacFadyen), Aging (Drs Gaziano, Kurth, Sesso, and Buring), and Cardiovascular Disease (Dr Gaziano), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System (Dr Gaziano), Boston; Department of Ambulatory Care and Prevention (Dr Buring), Harvard Medical School, Boston; and Departments of Epidemiology and Biostatistics (Drs Glynn, Kurth, Manson, and Sesso), Harvard School of Public Health, Boston.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Randomized Trials of Antioxidant Supplementation for Cancer Prevention: First Bias, Now Chance—Next, Cause
Peter H. Gann
JAMA. 2009;301(1):102-103.
EXTRACT
| FULL TEXT
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Leslie G. Ford, Howard L. Parnes, Lori M. Minasian, J. Michael Gaziano, Jo Ann Hartline, J. Kellogg Parsons, James D. Bearden, III, E. David Crawford, Gary E. Goodman, Jaime Claudio, Eric Winquist, Elise D. Cook, Daniel D. Karp, Philip Walther, Michael M. Lieber, Alan R. Kristal, Amy K. Darke, Kathryn B. Arnold, Patricia A. Ganz, Regina M. Santella, Demetrius Albanes, Philip R. Taylor, Jeffrey L. Probstfield, T. J. Jagpal, John J. Crowley, Frank L. Meyskens, Jr, Laurence H. Baker, and Charles A. Coltman, Jr
JAMA. 2009;301(1):39-51.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES)
Schleicher et al.
Am. J. Clin. Nutr. 2009;90:1252-1263.
ABSTRACT
| FULL TEXT
Use of Supplements of Multivitamins, Vitamin C, and Vitamin E in Relation to Mortality
Pocobelli et al.
Am J Epidemiol 2009;170:472-483.
ABSTRACT
| FULL TEXT
What's new in prostate cancer screening and prevention?
KLEIN
Cleveland Clinic Journal of Medicine 2009;76:439-445.
ABSTRACT
| FULL TEXT
What does it take to put an ugly fact through the heart of a beautiful hypothesis?
Haynes and Haynes
Evid. Based Med. 2009;14:68-69.
FULL TEXT
Associations between {alpha}-Tocopherol, {beta}-Carotene, and Retinol and Prostate Cancer Survival
Watters et al.
Cancer Res. 2009;69:3833-3841.
ABSTRACT
| FULL TEXT
Nutritional Prevention of Cancer: New Directions for an Increasingly Complex Challenge
Kristal and Lippman
JNCI J Natl Cancer Inst 2009;101:363-365.
FULL TEXT
Selenium and Vitamin E: Interesting Biology and Dashed Hope
Klein
JNCI J Natl Cancer Inst 2009;101:283-285.
FULL TEXT
Antioxidants: SELECTed out?
Block
Integr Cancer Ther 2009;8:5-8.
Commentary: Antioxidants for Cancer: New Tricks for an Old Dog?
Sharifi
The Oncologist 2009;14:213-215.
ABSTRACT
| FULL TEXT
Vitamin Supplementation and Prostate Cancer
JWatch General 2009;2009:1-1.
FULL TEXT
Randomized Trials of Antioxidant Supplementation for Cancer Prevention: First Bias, Now Chance--Next, Cause
Gann
JAMA 2009;301:102-103.
FULL TEXT
Prostate Cancer Prevention: The Role of 5-alpha-reductase Inhibitors
Kramer
Am Soc Clin Oncol Ed Book 2009;2009:65-69.
ABSTRACT
| FULL TEXT
Current Status of Chemoprevention of Prostate Cancer
Klein and Thompson
Am Soc Clin Oncol Ed Book 2009;2009:276-281.
ABSTRACT
| FULL TEXT
|
